Event Date/Time: Jun 05, 2010
End Date/Time: Jun 05, 2010
The New Biology of Lung Cancer: Changing Paradigms in Personalized Medicine, a CME-certified satellite symposium, will inform participants of the emerging diversity of lung cancer and the implications for individualized therapy. The newfound importance of biomarkers in treatment decision making will be emphasized, followed by other current topics of interest, such as maintenance therapy. Selected use of targeted agents, including EGFR and angiogenesis inhibitors, will be discussed, as will novel targets including EML4-ALK. Didactic lectures from lung cancer experts will set the stage for a case-based panel discussion session and opportunities for participants to interact with faculty.
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.
This meeting is complimentary.